Hemophilia Treatment Market : Growth Opportunities to Tap into in 2022-2027

 Fairfield Market Research finds that the global hemophilia treatment market is poised to reach a total market valuation of US$ 21, 349 million by 2027, registering a CAGR of 5.2% over the study period. The global hemophilia treatment market recorded a revenue of US$ 14,785.4 million in 2021. Considering this, the expected market share is a strong indicator of the fruitful business opportunities floating across the market. Key growth drivers include the widespread prevalence of diseases pertaining to blood clotting and intense innovation in novel therapeutics.

 


Hemophilia is a rare recessive bleeding disorder that poses difficulties in blood clotting. Although it is prevalent in relatively smaller population size, the incidence of hemophilia has surged significantly in recent years. As a result, government institutions and international health agencies are driven to embrace novel procedures and techniques to treat hemophilia. In addition to developing innovative treatments, world health leaders also strive to enhance awareness about early-stage diagnosis and treatment of hemophilia. These factors are poised to generate favourable business outcomes for the global hemophilia treatment market. In the near future, leading manufacturers are projected to engage in open innovation and strategic partnerships, creating headways for robust growth in the global hemophilia treatment market.

Request for Sample Copy ☛ https://www.fairfieldmarketresearch.com/report/hemophilia-treatment-market/request-sample

  

Novel Therapeutics Facilitate Advanced Hemophilia Treatment, Sound Business Outcomes

 

An increase in the adoption of novel therapeutics namely, biphasic antibodies, extended half-life factor concentrates (FVIII/FIX), hemophilia gene therapy, and targeting of natural anticoagulant pathways are projected to substantially enhance the treatment of hemophilia in the coming years. New clotting factor concentrates (CFCs) have notably reduced the concerns around patient care. However, further developments in novel therapeutics, particularly those related to treatment efficacy and convenience, are a pressing demand. In 2019, on the basis of treatment type, the recombinant factor concentrates segment held the largest market share of ~45%. Over the forecast period, this segment is poised to sustain this market dominance. Moreover, in terms of application type, the prophylaxis segment is set to witness the highest growth between 2022 to 2027, reaching a total market value of US$ 8 billion by the end of the study period.

 

Despite this promising business scenario, the lack of cost-effective treatments and concerns around the efficacy of modern hemophilia treatments are anticipated to restrict growth of the global hemophilia treatment market. Industry players are expected to tackle these challenges through government rebates, awareness campaigns, and collaboration.

 

North America to Sustain Global Dominance

 

In terms of volume, North America is poised to continue its dominance over the global hemophilia treatment market. In 2022, North America observed a total market valuation of US$ 6,481 million – this is set to rise to US$ 7,899 million by 2027, growing at a CAGR of 4.0%. In this region, the presence of key market players, higher per capita income, availability of government rebates, strong R&D in the health sector, and widespread awareness about hemophilia treatment are the major factors that contribute to the growth of the global hemophilia treatment market. Further, during the forecast period, the Asia Pacific is anticipated to demonstrate the fastest growth, registering a robust CAGR of 7.2%.

 

Prominent market players in the global hemophilia treatment market include Novo Nordisk, F. Hoffman La Roche Ltd., Bayer AG, Medexus Pharmaceuticals Inc., BioMarin Pharmaceuticals, Inc., Takeda Pharmaceuticals Company Ltd., Pfizer Inc, Octapharma AG, and CSL Behring among others.

 

About Us
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.

 

Contact
Fairfield Market Research
London, UK
UK +44 (0)20 30025888   
USA (Toll-free) +1 (844) 3829746 
Web: https://www.fairfieldmarketresearch.com/
Email: sales@fairfieldmarketresearch.com
Follow Us: LinkedIn

 

 

 

 

 

 

 

Comments

Post a Comment

Popular posts from this blog

Economic Realignment: Forecasting the Clear Aligners Market (2023 - 2029)

Image
 The global market for clear aligners is currently having a significant impact on the dentistry sector in addition to building a solid reputation for itself. Between 2023 and 2029, Clear Aligners are expected to rise at a staggering 19.8% annual pace, revolutionizing orthodontic treatment and surpassing a market value of US$23.8 billion. Clear aligners have revolutionized the field of dentistry by providing a more useful, comfortable, and aesthetically appealing alternative to traditional metal braces. The World Health Organization considers malocclusions as the third-biggest oral health problem, behind periodontal disease and cavities, and they are now the preferred way of treatment. For more information, please refer to the full report: https://www.fairfieldmarketresearch.com/report/clear-aligners-market Unmasking the Potential: The Rising Demand for Efficient Dental Care With aesthetic appeal and functionality at the forefront, effective orthodontic treatments like clear ...
Read more

Acute Lung Injury Treatment Market Growth and key Industry Players, 2022 Analysis and Forecast

Image
  global Acute lung injury treatment market owing to the high prevalence of lung-related diseases & leading causes of morbidity among critically-ill patients worldwide. These disorders have a high fatality rate as a disrupted supply of oxygen can have adverse side effects on the body. Restricted oxygen supply to the brain can lead to cardiac arrest which has a survival rate of less than 10%. The grave nature of acute lung injury has increased the demand for effective treatments to mitigate associated risks. Prominent industry players in the acute lung injury treatment market are investing significantly to develop advanced treatments and therapies against acute lung injury. In the foreseeable future, this business landscape is anticipated to create headways for growth in the global acute lung injury treatment market, with a special focus on healthcare innovation, M&A, and aggressive R&D across international markets.   Looking For a Sample Copy of This Report? Req...
Read more

KSA Medical Devices Market Projects Strong Growth, Reaching US$2 Billion in 2022

Image
The KSA Medical Devices Market, which registered a valuation of US$2 billion in 2022, anticipates witnessing a promising pace of growth in the coming years. This expansion is spurred by significant shifts towards homecare settings, the escalating prevalence of chronic diseases, and the growing demand for cost-effective healthcare services outside hospitals. For more information, please refer to the full report: https://www.fairfieldmarketresearch.com/report/ksa-medical-devices-market   / The KSA market also opens up opportunities for the rising preference for wearable devices and the requirement for enhanced healthcare monitoring during emergencies. Fitness trackers are rapidly gaining popularity among consumers, and the continuous monitoring provided by these devices can significantly improve healthcare outcomes during crises. "The move towards homecare solutions is dramatically changing the healthcare landscape," says a top market analyst. "The demand for speci...
Read more